Robeco Institutional Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,447
Closed -$266K 956
2024
Q1
$266K Hold
1,447
﹤0.01% 893
2023
Q4
$260K Buy
1,447
+377
+35% +$58.7K ﹤0.01% 895
2023
Q3
$170K Sell
1,070
-214
-17% -$35K ﹤0.01% 934
2023
Q2
$182K Buy
1,284
+80
+7% +$12.8K ﹤0.01% 950
2023
Q1
$203K Sell
1,204
-1,466
-55% -$262K ﹤0.01% 940
2022
Q4
$452K Buy
+2,670
New +$484K ﹤0.01% 851
2022
Q2
Sell
-54
Closed -$10K 954
2022
Q1
$10K Hold
54
﹤0.01% 914
2021
Q4
$14K Hold
54
﹤0.01% 896
2021
Q3
$16K Hold
54
﹤0.01% 908
2021
Q2
$11K Hold
54
﹤0.01% 943
2021
Q1
$10K Buy
+54
New +$11.1K ﹤0.01% 943

Other funds holding RGEN

Robeco Institutional Asset Management's RGEN Position: Q2 2024 in Review

Robeco Institutional Asset Management sold out of Repligen (RGEN) in Q2 2024, closing a stake of 1,447 shares — an estimated $266K sold.

Robeco Institutional Asset Management first reported a position in RGEN in Q1 2021 and held it in 11 quarters. The position peaked at $452K in Q4 2022. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Robeco Institutional Asset Management reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 1,447 Repligen shares in Q2 2024, an estimated $266K.
  • Robeco Institutional Asset Management first reported a position in Repligen in Q1 2021 and held it in 11 quarters.
  • Robeco Institutional Asset Management's Repligen position peaked at $452K in Q4 2022.
  • 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2024, filed 23 Jul 2024.